Diaphragmatic Effects of Combined Infraclavicular Brachial Plexus Block and Suprascapular Nerve Block
ICB-SNB
Evaluation of the Effects of Combined Infraclavicular Brachial Plexus Block and Suprascapular Nerve Block on the Diaphragm in Arthroscopic Shoulder Surgery
1 other identifier
observational
61
1 country
1
Brief Summary
This prospective observational study was conducted to evaluate the effects of a combined infraclavicular brachial plexus block and anterior suprascapular nerve block on diaphragmatic function in patients undergoing arthroscopic shoulder surgery. A total of 61 adult patients were enrolled in the study. Diaphragmatic excursion was assessed using ultrasonography both prior to block administration and 30 minutes following the procedure during normal and deep breathing. The primary objective was to assess changes in diaphragmatic excursion and determine the incidence of hemidiaphragmatic paralysis associated with this combined block technique. Secondary outcomes included block performance time, duration of postoperative analgesia, the need for additional intraoperative sedation or analgesia, the occurrence of adverse events, and levels of patient and surgeon satisfaction. The study sought to determine whether this regional anesthesia approach could provide effective anesthesia and analgesia while minimizing impairment of diaphragmatic function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2025
CompletedFirst Submitted
Initial submission to the registry
May 31, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedJune 10, 2026
June 1, 2026
5 months
May 31, 2026
June 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Diaphragmatic Excursion at 30 Minutes After Block Administration
Diaphragmatic excursion measured by ultrasonography during normal and deep breathing before block administration and 30 minutes after block administration. The percentage change from baseline was calculated.
30 minutes after block administration
Secondary Outcomes (6)
Incidence of Hemidiaphragmatic Paralysis
30 minutes after block administration
Degree of Hemidiaphragmatic Paralysis
30 minutes after block administration
Block Performance Time
From needle insertion to completion of the block procedure
Additional Intraoperative Analgesia Requirement
From surgical incision to the end of surgery
Time to First Analgesic Requirement
Up to 24 hours after surgery
- +1 more secondary outcomes
Study Arms (1)
Patients Undergoing Arthroscopic Shoulder Surgery
Patients undergoing arthroscopic shoulder surgery who received a combined infraclavicular brachial plexus block and anterior suprascapular nerve block. Diaphragmatic excursion was evaluated using ultrasonography before and after block administration.
Eligibility Criteria
Adult patients aged 18-80 years with ASA physical status I-III undergoing elective arthroscopic shoulder surgery at Gazi University Faculty of Medicine Hospital. Eligible participants received ultrasound-guided combined infraclavicular brachial plexus block and anterior suprascapular nerve block. The study evaluated changes in diaphragmatic excursion measured by ultrasonography before and after block administration.
You may qualify if:
- Patients aged 18-80 years.
- ASA physical status I-III.
- Scheduled for elective arthroscopic shoulder surgery.
- Ability to provide written informed consent
You may not qualify if:
- Refusal to undergo peripheral nerve block.
- Pre-existing peripheral neuropathy.
- Known pulmonary, hepatic, or renal disease.
- Allergy to local anesthetics.
- Infection at the block site.
- Pre-existing neurological deficit.
- Body mass index (BMI) \> 40 kg/m².
- Coagulopathy.
- Sepsis.
- Previous surgery at the planned block site.
- Major psychiatric disorders.
- Inability to complete diaphragmatic ultrasonographic assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Medicine Hospital
Ankara, Ankara, 06500, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
IRFAN GUNGOR, MD
Gazi university faculty of medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology Resident
Study Record Dates
First Submitted
May 31, 2026
First Posted
June 10, 2026
Study Start
February 22, 2025
Primary Completion
July 20, 2025
Study Completion
July 20, 2025
Last Updated
June 10, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data collected during the study will not be shared with other researchers because of institutional policies, ethical considerations, and protection of participant confidentiality.